<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02458586</url>
  </required_header>
  <id_info>
    <org_study_id>UFOP-2</org_study_id>
    <nct_id>NCT02458586</nct_id>
  </id_info>
  <brief_title>Ernährungs-Interventions-Fettleber-Studie (Interventional Study on Nutritional Effects on NAFLD)</brief_title>
  <acronym>UFOP-2</acronym>
  <official_title>Ernährungs-Interventions-Fettleber-Studie (Interventional Study on Nutritional Effects on NAFLD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>German Institute of Human Nutrition</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ufop: Union zur Förderung von Oel- und Proteinpflanzen e.V.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>German Institute of Human Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epidemiological data and studies in animal models suggest, that polyunsatured fatty acids
      (PUFA) rather than mono-unsatured fatty acids (MUFA) are associated with lower hepatic lipid
      content (HCL) and may facilitate a decrease of HCL in case of non-alcoholic fatty liver
      disease (NAFLD).

      The investigators therefore conduct an interventional trial in subjects with normal glucose
      metabolism, but increased HCL, fulfilling criteria for NAFLD.

      The study will compare two dietary interventions in parallel design, one containing mainly
      PUFA (canola oil), one containing only MUFA (olive oil). The intervention of 8 weeks is
      accomodated by dietary counseling. Metabolic outcome variables will be assessed with MR
      spectroscopy (liver fat) and euglycemic hepatic clamp (glucose metabolism/insulin
      sensitivity).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epidemiological data and studies in animal models suggest, that polyunsatured fatty acids
      (PUFA) rather than mono-unsatured fatty acids (MUFA) are associated with lower hepatic lipid
      content (HCL) and may facilitate a decrease of HCL in case of non-alcoholic fatty liver
      disease (NAFLD). A typical source for PUFAs are fish and certain plant oils, a source of
      almost pure MUFAs is olive oil.

      The investigators therefore conduct an interventional trial in subjects with normal glucose
      metabolism, but increased HCL, fulfilling criteria for NAFLD. The investigation focusses on
      male participants to avoid sex-related differences in the results.

      The study will compare two isocaloric dietary interventions in parallel design, one
      containing mainly PUFA (canola oil), one containing only MUFA (olive oil). The intervention
      of 8 weeks is accomodated by dietary counseling (4 sessions). Metabolic outcome variables
      will be assessed with MR spectroscopy (liver fat), anthropometry (to check for stable weight
      and body composition) and euglycemic hepatic clamp (glucose metabolism/insulin sensitivity).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in liver fat content</measure>
    <time_frame>4 and 8 weeks</time_frame>
    <description>change in liver fat content (MR spectroscopy and ultrasound)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in hepatic insulin sensitivity</measure>
    <time_frame>8 weeks only</time_frame>
    <description>change in hepatic insulin sensitivity (euglycemic hepatic clamp)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>NAFLD</condition>
  <condition>Obesity</condition>
  <condition>Prediabetes</condition>
  <condition>Dyslipoproteinemia</condition>
  <arm_group>
    <arm_group_label>MUFA</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>daily intake of 50 g of olive oil over a period of 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PUFA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>daily intake of 50 g of canola oil (rapeseed oil) over a period of 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dietary intervention / counseling</intervention_name>
    <description>dietary counseling and daily intake of 50 g of dietary oil over a period of 8 weeks</description>
    <arm_group_label>MUFA</arm_group_label>
    <arm_group_label>PUFA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  increased hepatic fat content (NAFLD)

          -  BMI between 30 and 35 kg/m²

        Exclusion Criteria:

          -  diabetes

          -  severe cardiac, pulmonary or gastrointestinal disorders

          -  hepatic disorders other than NAFLD

          -  alcoholism

          -  medication with metabolic side or main effects (e.g. statins)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Margrit Kemper, Dr.</last_name>
    <phone>033 200</phone>
    <phone_ext>88 2775</phone_ext>
    <email>margrit.kemper@dife.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Berit Schmidt</last_name>
    <phone>033 200</phone>
    <phone_ext>88 2771</phone_ext>
    <email>berit.schmidt@dife.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>German Institut for Human Nutrition; Department for Clinical Nutrition</name>
      <address>
        <city>Nuthetal</city>
        <state>Brandenburg</state>
        <zip>14458</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margrit Kemper, Dr. med.</last_name>
      <phone>033200 88 2775</phone>
      <email>margrit.kemper@dife.de</email>
    </contact>
    <contact_backup>
      <last_name>Silke Hornemann</last_name>
      <phone>033200 88 2779</phone>
      <email>silke.hornemann@dife.de</email>
    </contact_backup>
    <investigator>
      <last_name>Margrit Kemper, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silke Hornemann</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christiana Gerbracht, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2015</study_first_submitted>
  <study_first_submitted_qc>May 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 1, 2015</study_first_posted>
  <last_update_submitted>November 21, 2016</last_update_submitted>
  <last_update_submitted_qc>November 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>German Institute of Human Nutrition</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Andreas F. H. Pfeiffer</investigator_full_name>
    <investigator_title>Head of Department of Clinical Nutrition</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

